Harvey E. Behrend

Array ( [id] => 1436044 [patent_doc_number] => 06355688 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Remedy for autoimmune diseases' [patent_app_type] => B1 [patent_app_number] => 09/516435 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3261 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355688.pdf [firstpage_image] =>[orig_patent_app_number] => 09516435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416824 [patent_doc_number] => 06511983 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Pharmaceutical combination of antiviral agents' [patent_app_type] => B1 [patent_app_number] => 09/515328 [patent_app_country] => US [patent_app_date] => 2000-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9791 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511983.pdf [firstpage_image] =>[orig_patent_app_number] => 09515328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683996 [patent_doc_number] => 20030119860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'METHOD FOR TRATMENT OF NON-RHEUMATOID ARTHRITIS' [patent_app_type] => new [patent_app_number] => 09/486472 [patent_app_country] => US [patent_app_date] => 2000-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28147 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119860.pdf [firstpage_image] =>[orig_patent_app_number] => 09486472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241261 [patent_doc_number] => 06683084 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections' [patent_app_type] => B1 [patent_app_number] => 09/505745 [patent_app_country] => US [patent_app_date] => 2000-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1588 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683084.pdf [firstpage_image] =>[orig_patent_app_number] => 09505745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1404479 [patent_doc_number] => 06534512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Dideoxycarbocyclic nucleosides' [patent_app_type] => B1 [patent_app_number] => 09/504459 [patent_app_country] => US [patent_app_date] => 2000-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8172 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534512.pdf [firstpage_image] =>[orig_patent_app_number] => 09504459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446983 [patent_doc_number] => 06369100 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Method for inhibiting gene expression promoted by AP1 protein with RAR selective retinoids and method for treatment of diseases and conditions with such retinoids' [patent_app_type] => B1 [patent_app_number] => 09/482589 [patent_app_country] => US [patent_app_date] => 2000-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 15686 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369100.pdf [firstpage_image] =>[orig_patent_app_number] => 09482589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1343353 [patent_doc_number] => 06586473 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Topical drug delivery composition and method' [patent_app_type] => B1 [patent_app_number] => 09/481813 [patent_app_country] => US [patent_app_date] => 2000-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3604 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586473.pdf [firstpage_image] =>[orig_patent_app_number] => 09481813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113155 [patent_doc_number] => 06803375 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Non-peptide inhibition of T-lymphocyte activation and therapies related thereto' [patent_app_type] => B1 [patent_app_number] => 09/479391 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11367 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 363 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803375.pdf [firstpage_image] =>[orig_patent_app_number] => 09479391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113155 [patent_doc_number] => 06803375 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Non-peptide inhibition of T-lymphocyte activation and therapies related thereto' [patent_app_type] => B1 [patent_app_number] => 09/479391 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11367 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 363 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803375.pdf [firstpage_image] =>[orig_patent_app_number] => 09479391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113155 [patent_doc_number] => 06803375 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Non-peptide inhibition of T-lymphocyte activation and therapies related thereto' [patent_app_type] => B1 [patent_app_number] => 09/479391 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11367 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 363 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803375.pdf [firstpage_image] =>[orig_patent_app_number] => 09479391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113155 [patent_doc_number] => 06803375 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Non-peptide inhibition of T-lymphocyte activation and therapies related thereto' [patent_app_type] => B1 [patent_app_number] => 09/479391 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11367 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 363 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803375.pdf [firstpage_image] =>[orig_patent_app_number] => 09479391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1485769 [patent_doc_number] => 06365623 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Treatment of acne using lipoic acid' [patent_app_type] => B1 [patent_app_number] => 09/475514 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6125 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365623.pdf [firstpage_image] =>[orig_patent_app_number] => 09475514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534979 [patent_doc_number] => 06489330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Use of penciclovir for the treatment of human herpes-virus-8' [patent_app_type] => B1 [patent_app_number] => 09/473888 [patent_app_country] => US [patent_app_date] => 1999-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1392 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489330.pdf [firstpage_image] =>[orig_patent_app_number] => 09473888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1289371 [patent_doc_number] => 06632806 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Neurologically-active compounds' [patent_app_type] => B1 [patent_app_number] => 09/446721 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7116 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632806.pdf [firstpage_image] =>[orig_patent_app_number] => 09446721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253561 [patent_doc_number] => 06670351 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-30 [patent_title] => 'Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1' [patent_app_type] => B1 [patent_app_number] => 09/469817 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3695 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670351.pdf [firstpage_image] =>[orig_patent_app_number] => 09469817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1520934 [patent_doc_number] => 06413944 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Triciribine and analogs as antiviral drugs' [patent_app_type] => B1 [patent_app_number] => 09/466779 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4866 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413944.pdf [firstpage_image] =>[orig_patent_app_number] => 09466779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440582 [patent_doc_number] => 20020128326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'TOPICAL IMMUNOMODULATING COMPOSITIONS FOR TREATMENT OF AIDS, HEPATITIS B&C, OTHER INFECTIOUS DISEASES, AND CANCER' [patent_app_type] => new [patent_app_number] => 09/459935 [patent_app_country] => US [patent_app_date] => 1999-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1453 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128326.pdf [firstpage_image] =>[orig_patent_app_number] => 09459935 [rel_patent_id] =>[rel_patent_doc_number] =>)